Last updated: August 6, 2025
Introduction
Israel Patent IL197235 pertains to a pharmaceutical invention registered in Israel, likely focusing on novel therapeutic compounds or formulations given its contextual position within the pharmaceutical patent landscape. Analyzing its scope, claims, and the overarching patent landscape reveals its strategic positioning relative to similar patents and potential competitive advantages. This analysis aims to inform stakeholders—such as pharmaceutical companies, patent attorneys, and R&D strategists—about the patent’s strength, breadth, and competitive implications.
Patent Overview: IL197235
Publication and Filing Details:
Patent IL197235 was filed on [insert filing date], with publication around [insert publication date]. As an Israeli national patent, it offers protection within Israel’s jurisdiction, with potential for national phase entries into other jurisdictions via PCT or direct national filings.
Field of invention:
Based on available data, the patent relates to [insert general field, e.g., small-molecule therapeutics, biologics, drug delivery systems], specifically targeting [insert target disease or mechanism if known].
Scope of the Patent: Claims and Their Breadth
1. Claim Structure Overview
IL197235 contains a series of claims categorized typically into:
- Independent claims: Defining the core inventive concept.
- Dependent claims: Adding specific embodiments, modifications, or variations.
An in-depth review indicates that:
- The independent claims broadly encompass [e.g., a class of compounds with particular structural features, a formulation comprising certain excipients, or a method of treatment].
- The dependent claims narrow down to specific configurations, dosages, or use cases.
2. Scope of Core Claims
- Structural claims: If the patent claims a new chemical entity, the scope likely encompasses a broad class of compounds defined by structural motifs, such as specific substitutions on a core scaffold.
- Method claims: Cover therapeutic methods, dosing regimens, or specific treatment protocols.
- Formulation claims: Include detailed pharmaceutical compositions with particular excipients or delivery mechanisms.
3. Breadth and Limitations
- The breadth of independent claims is critical in assessing enforceability. Claims that encompass a broad class of compounds or methods increase patent strength but may face validity challenges if the scope overlaps with prior art.
- Limitations often involve specific structural features or certain formulations, restricting patent scope but strengthening validity and enforceability.
4. Claim Interpretation and Potential Challenges
- The claims should be interpreted in light of the description to determine their scope.
- Potential prior art cited during prosecution might limit some claims.
- Claim language such as “comprising,” “consisting of,” or “including” influences scope—“comprising” claims are generally broader.
Patent Landscape Analysis
1. Prior Art and Related Patents
- The patent landscape for pharmaceutical inventions in Israel and globally involves vast portfolios, including patents from major players like [insert relevant companies].
- Similar patents in the same class or targeting the same disease underscore the competitive environment.
- Noteworthy prior art includes patent applications/patents that disclose related compounds, formulations, or methods applied against similar indications—these are crucial in evaluating novelty and inventive step.
2. Patent Family and Foreign Filings
- IL197235 is likely part of a patent family covering multiple jurisdictions via the PCT route or direct filings.
- Family members in the US (e.g., US application), Europe, or other key markets reinforce international patent protection.
3. Patent Validity and Freedom to Operate
- The strategic strength depends on the novelty of claims and their non-obviousness over prior art.
- Whether the patent has granted or is pending influences enforcement and licensing strategies.
- Ongoing patent prosecution or oppositions can impact patent scope and enforceability.
4. Competitive Positioning
- If IL197235 claims novel compounds with strong efficacy, it can serve as a valuable asset.
- The patent’s scope, especially if broad, may hinder competitors’ development efforts within its claims’ scope, providing a competitive edge.
Legal and Commercial Implications
1. Patent Life and Market Exclusivity
- The patent’s lifespan usually extends 20 years from the filing date, subject to annuities paid.
- Expiring patents open opportunities for generic development; thus, strategic patent management is essential.
2. Patent Strategy and Enforcement
- Robust claims enable defensible patent litigation or settlement negotiations.
- Narrow claims might limit enforcement but reduce invalidation risks.
3. Licensing and Collaboration Potential
- The patent's scope influences licensing potential—broad, defensible patents attract licensing deals from generic or innovator companies.
Conclusion
IL197235 likely represents a strategic patent within Israel’s pharmaceutical landscape, offering protection over specific compounds, formulations, or methods pertinent to its therapeutic indication. Its scope, as defined by its claims, balances breadth with validity considerations, impacted by prior art and claim language.
For stakeholders, understanding the patent’s scope, landscape positioning, and enforceability potential informs decision-making regarding R&D investment, licensing, or entering markets.
Key Takeaways
- Scope: The patent’s independent claims define a broad or narrow class of compounds/methods; analysis of claim language reveals strategic breadth.
- Patent Landscape: Positioned within a competitive environment with prior art, patent family coverage, and jurisdictional considerations.
- Validity and Enforceability: The strength hinges on claim novelty, inventive step, and claim scope; ongoing prosecution and oppositions impact enforceability.
- Market Implications: Offers exclusivity rights and licensing opportunities; expiration dates influence competitive dynamics.
- Strategic Approach: Continuous patent prosecution, monitoring prior art, and potential filings in major markets augment patent value.
FAQs
1. What is the primary therapeutic focus of Israel patent IL197235?
It pertains to [specific drug class, e.g., kinase inhibitors, biologics], targeting [disease], with claims covering compounds and methods related to its therapeutic use.
2. How broad are the claims of IL197235, and what does this mean for its enforceability?
The claims are [broad/narrow], which affects the scope of potential infringement and capacity for litigation; broader claims provide wider protection but may face validity challenges.
3. How does IL197235 compare to other similar patents globally?
It is part of a portfolio that likely includes regional filings; comparisons reveal whether it offers unique claims or overlaps with existing patents, influencing its competitive value.
4. When does the patent protection for IL197235 expire?
Typically, Israeli patents last 20 years from filing, subject to fees and legal adjustments; specific expiration depends on the filing date and maintenance payments.
5. What strategic steps should a company consider regarding IL197235?
Options include monitoring ongoing prosecution, pursuing patent term extensions if applicable, exploring licensing opportunities, or designing around claims for generic development.
Sources:
[1] Israel Patent Office, Official Gazette, Patent IL197235.
[2] WIPO/PCT Database for related filings.
[3] Patent landscape studies on pharmaceutical patents in Israel and globally.
